Regarding used normal Two-way crossover program was used for un-scaled average [Study As­sess­ment]

posted by Sivakrishna – India, 2020-06-01 13:47 (1862 d 04:18 ago) – Posting: # 21494
Views: 3,300

Dear All,

Good Afternoon,

One of my close friend asked the below query
Two-way cross over ANOVA model calculation was used for Unscaled average bio equivalence instead of Progesterone Guidelines program and study was submitted FDA regulatory. when he used the two-way crossover program study was met bio equivalence criteria (i.e., 80.00-125.00%). However, with the progesterone guidelines the study is not meeting Bio equivalence criteria for Cmax PK parameter (upper limit showing 126.14%). How can we justify this failure. please help to my friend.

Thanks in advance.

Thanks and Regards

G. Siva Krishna Teja.

Complete thread:

UA Flag
Activity
 Admin contact
23,428 posts in 4,929 threads, 1,681 registered users;
73 visitors (0 registered, 73 guests [including 17 identified bots]).
Forum time: 18:05 CEST (Europe/Vienna)

No matter what side of the argument you are on,
you always find people on your side
that you wish were on the other.    Thomas Berger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5